By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    improving patient experience
    6 Ways to Improve Patient Satisfaction Within Hospitals
    December 1, 2021
    degree for healthcare job
    What Are The Health Benefits Of Having A Degree?
    March 9, 2022
    custom software development is changing healthcare
    Digital Customer Journey Mapping and its Importance for Healthcare
    July 21, 2022
    Latest News
    7 Most Common Healthcare Accreditation Programs: Which Should You Use?
    August 20, 2025
    Hospital Pest Control and the Fight Against Superbugs
    August 20, 2025
    Hygiene Beyond The Clinic: Attention To Overlooked Non-Clinical Spaces
    August 13, 2025
    5 Steps to a Promising Career as a Healthcare Administrator
    August 3, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Options For Seniors Who Outlive Their Life Insurance Policy
    February 16, 2021
    What are the Protections for Mentally Ill People Under the American with Disabilities Act?
    April 2, 2018
    5 Key Healthcare Technology Predictions For 2019
    September 28, 2020
    Latest News
    How Social Security Disability Shapes Access to Care and Everyday Health
    August 20, 2025
    How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
    August 20, 2025
    How One Fall Can Lead to a Long Road of Medical Complications
    August 20, 2025
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Science for Sale: The Very Sad Case of Medtronic’s “Infuse”
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > Science for Sale: The Very Sad Case of Medtronic’s “Infuse”
BusinessMedical DevicesMedical Ethics

Science for Sale: The Very Sad Case of Medtronic’s “Infuse”

psalber
psalber
Share
7 Min Read
SHARE

Recently, I met with an Israeli naturopath who wanted to crowdfund his products on my new platform, Health Tech Hatch.   After about 20 minutes of discussion, it was clear that this doctor had absolutely no reliable data to support his claims (his product, he said, would improve or cure everything from Type 2 diabetes to psoriasis to retinal detachments – it also helps chickens gain weight faster and be healthy enough to be declared Health Tech Hatch.   After about 20 minutes of discussion, it was clear that this doctor had absolutely no reliable data to support his claims (his product, he said, would improve or cure everything from Type 2 diabetes to psoriasis to retinal detachments – it also helps chickens gain weight faster and be healthy enough to be declared Glatt Kosher).

My husband, an MD, PhD-type and I rather smugly told him we couldn’t possibly promote his ideas on our website unless he subjected his products to rigorous clinical trials.  Publication of the results of those trials in peer-reviewed journals are, after all, the gold standard.

Fast forward to the next day, October 25, 2012.   I am catching up on my email while eating lunch at the Tel Aviv Hilton when this headline on MedPage Today smacks me in the face:  Senate Investigation: Millions Paid for Positive Spin on Spine Fusion Product.   It is a story about Medtronic exerting undue influence (to say the least) on publications about its bone growth product, bone morphogenetic protein-2, whose brand name is “Infuse.” 

According to the MedPage Today story, written by John Fauber, a reporter with Milwaukee Journal Sentinel & MedPage Today,

More Read

Watch Four Health Startups Build Their Businesses on WSJ’s Reality TV-Style “Startup of the Year”
Affordable Care Act Hits Two-Year Mark
The Ethical Foundations of Health Policy
Public Employee Benefits Alliance (PEBA) Signs Agreement With Satori Medical Tourism
ACOs vs. Bundled Payments: Can Either Save Healthcare?

”Medtronic employees, including some working in the company’s marketing department, covertly collaborated with the academic physician authors in producing 11 different papers between 2002 and 2009.” 

Evidently, Medtronic employees were editing and in some cases writing parts of  papers that were published in important peer-reviewed journals, even to the point of obfuscating important data that might have been viewed as unfavorable to the product:

 “An email indicated that a Medtronic marketing employee, Julie Bearcroft, was involved in editing a 2005 Journal of Bone and Joint Surgery article and recommended against publishing a complete list complications related to the structural integrity of the fused area.  Those complications — known as implant migration, subsidence and end-plate fracture — had been observed in a clinical trial and had been formatted in a detailed table, according to an internal Medtronic email. But, following the advice of Bearcroft, that table was not included in the published paper.”

Not only that, but the so-called authors of the papers in question were making millions of dollars from their affiliation with the company:

“”The lead author of the paper, Ken Burkus, MD, a Columbus, Ga. surgeon, sent a draft of the paper to his co-authors with the note, “this manuscript documents the superiority in clinical and radiographic outcomes with (Infuse)…” Burkus, who got $6.4 million from Medtronic between 1998 through 2010, did not respond to an email seeking his comment.””

The article states that,

“Over the course of 15 years, Medtronic paid $210 million to a group of 13 doctors who co-authored the series of now-repudiated papers about the product. The payments also included two corporate entities associated with some of the doctors.”

Of course, Medtronic disputes these claims, saying,

“Medtronic vigorously disagrees with any suggestion that the company improperly influenced or authored any of the peer-reviewed published manuscripts discussed in the report, or that Medtronic intended to under-report adverse events…” 

Well, what would you expect them to say?  “Hey, it’s only business [really, really big] business.”

Iron pyrite (aka fool’s gold)

This type of story, sadly, is not new.  Pharma and medical device companies have been helping to write articles for publications for years.  Remember, the Neseritide story?  But what is so distressing is not that it happened, but that it keeps on happening.  And, that it is endangering the integrity and reputation peer-reviewed publications, with the distinct possibility of transforming the gold standard into fool’s gold.

Hey guys, these are just any old products.  They are products that can harm people or, at a minimum, do not help them.  In addition, millions of health care dollars are wasted paying for professionally hyped products that could be used to provide more effective, safer, and in many cases, less expensive treatments to many thousands of patients.

I realize that the word “regulation” is a dirty word in the highly charged atmosphere of a tightly contested election season.  But how else are we going to fix this problem? Clearly, industries as lucrative as medical devices and big pharma have proven themselves incapable of policing themselves.  An unfettered market may be good for profits, but, in my opinion, is not good for patients.  Regulation, independent oversight, financial and criminal penalties need to be brought into play so that companies tempted to cross the line will know there are consequences.

If you have a better idea about how we can curb these type of abuses, I would love to hear it.

The full text of the article under discussion can be found on MedPage Today.

 

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

engineer fitting prosthetic arm
How Social Security Disability Shapes Access to Care and Everyday Health
Health care
August 20, 2025
a woman explaining the document
How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
Public Health
August 20, 2025
physiotherapist at work
How One Fall Can Lead to a Long Road of Medical Complications
Health care
August 20, 2025
Common Healthcare Accreditation Programs
7 Most Common Healthcare Accreditation Programs: Which Should You Use?
Health News
August 20, 2025

You Might also Like

obamacare tax credits
BusinessFinanceHealth ReformPolicy & LawPublic Health

Almost Anyone Can Claim ObamaCare Tax Credits

March 11, 2014

Aetna To Buy Coventry Healthcare for $5.7 Billion in Cash and Stock

August 20, 2012
purpose WHY
BusinessHospital Administration

Politics or Purpose: What’s Driving Your Hospital Marketing?

February 24, 2016
ear surgery
Medical DevicesMedical InnovationsTechnology

Congenital Hearing Deformities at the Brink of a Breakthrough

January 12, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?